Login

John Lai, CEO/President of PetVivo Holdings, Inc., discusses game-changing innovations in a segment interview. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jeffrey Gundlach Analyzes Fed Policy, Inflation, and Market Outlook | Jeffrey Gundlach, CEO , DoubleLine Capital.
00:10:00
Nowadays technology is much more useful than ever|Cat Hernandez,General Partner, The Venture Collective (TVC)
00:00:00
Anna Ljung, CEO, Moberg Pharma AB (publ)
00:10:00
Equinox Gold's Path to 1 Million Ounces of Annual Gold Production
00:10:00
Rincon Resources CEO Discusses Exploration Plans and Prospects for 2021 on Assay TV
00:10:00
Jungheinrich CEO: From Challenges to Comeback | Lars Brzoska - CEO of Jungheinrich
00:10:00
Insights on Electricity Prices, Property Segments, and the Future of Offices from Castellum's CEO | Rutger Arnhult, CEO,Castellum AI
00:10:00
Gateley: Balancing Profit with Purpose | Rod Waldie - CEO & Partner of Gateley (Holdings) PLC
00:10:00
PIC CEO Abel Reflects on Asset Growth, Market Recovery, and Social Impact Amidst Pandemic Turbulence | Abel Sithole, CEO , Public Investment Corporation.
00:10:00
Navigating the Changing IPO Landscape: Insights from a 50-Year Veteran
00:10:00
Investment funds to customize control and seamlessly execute primary and secondary transactions|Barry Silbert,Ceo,SecondMarket
00:10:00
Conversations with Dan Houston: A Journey of Leadership, Service, and Resilience | Dan Houston, CEO, Principal Financial Group.

© 2017 - Neuhu+